Faldaprevir shows promise treating hepatitis C, study says

05/10/2013 | Medscape (free registration)

A short course of faldaprevir taken with pegylated interferon and ribavirin successfully clears the hepatitis C virus, Austrian researchers told a liver conference. The study found that while more than nine out of 10 patients had an adverse event, a relatively small number were serious, with anemia being the most common problem.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC